GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.
View Top Employees from GI INNOVATIONWebsite | http://www.gi-innovation.com |
Revenue | $6 million |
Employees | 33 (29 on RocketReach) |
Founded | 2017 |
Address | 송파구 송파대로 167 문정역테라타워 A동 1116호, Seoul, Seoul 05855, KR |
Technologies |
JavaScript,
HTML,
jQuery
+7 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular GI INNOVATION employee's phone or email?
The GI INNOVATION annual revenue was $6 million in 2024.
Young Oh is the Executive Vice President of GI INNOVATION.
29 people are employed at GI INNOVATION.
GI INNOVATION is based in Seoul, Seoul.
The NAICS codes for GI INNOVATION are [54, 5417, 541713, 54171, 541].
The SIC codes for GI INNOVATION are [87, 873].